ClinicalTrials.Veeva

Menu

Effect of Skanlab Regarding Knee Arthrosis

O

Oslo Metropolitan University

Status

Unknown

Conditions

Arthrosis

Treatments

Other: Skanlab bodywave

Study type

Interventional

Funder types

Other

Identifiers

NCT02649296
Skanlab

Details and patient eligibility

About

The purpose is to find out the effect of Skanlab at knee arthrosis.

Full description

The patients diagnosed with knee arthrosis will be treated With Skanlab twice a week for four weeks.

Enrollment

16 estimated patients

Sex

All

Ages

45 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • knee arthrosis in one or both legs

Exclusion criteria

  • Pacemaker
  • infusion pump
  • cancer
  • diabetes
  • pregnancy
  • blood clots
  • bacteriological inflammation
  • reduced sensitivity in the treatment area.

Trial design

16 participants in 2 patient groups

Treatment with Skanlab Bodywave
Other group
Description:
Treatment with Skanlab Bodywave twice a week for four weeks at the affected knee.
Treatment:
Other: Skanlab bodywave
No treatment
No Intervention group
Description:
Treatment with Skanlab Bodywave without function twice a week for four weeks.

Trial contacts and locations

1

Loading...

Central trial contact

Hilde Sylliaas, Ass prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems